# DEBRA Research

> DEBRA Research is a VC fund in Munich backing Biotechnology, Fitness and Medical. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Munich, Germany
- Total investments: 4
- Last investment: Jul 2026
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/debra-research
- Website: https://www.debra-research.org

DEBRA Research is a non-profit organization that serves as the research arm of DEBRA Austria and operates globally. Its primary focus is on translational research and clinical development aimed at creating therapies and eventual cures for Epidermolysis Bullosa (EB), a rare and debilitating genetic skin disorder that causes extreme skin fragility,blistering, and chronic wounds. mission is to identify, promote, fund, and manage the most promising research projects to alleviate symptoms and ultimately cure EB

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 50% |
| Fitness | 1 | 25% |
| Medical | 1 | 25% |
| Wellness | 1 | 25% |
| Health Care | 1 | 25% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 2 | 50% |
| Seed | 1 | 25% |
| Venture - Series Unknown | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Healome Therapeutics | Healome Therapeutics | $2.7M | Seed | Jul 07, 2026 |  |
| Eliksa Therapeutics | Eliksa Therapeutics is a biotechnology company that develops regenerative medicine. |  |  | Oct 29, 2025 |  |
| Dermaliq Therapeutics | Dermaliq is developing the next generation of skin care therapies to enhance targeted penetration into skin tissues and to reduce unwanted side effects for millions of patients. The proprietary technology now owned by Dermaliq, called hyliQ™, is designed to allow cutaneous drug delivery with bioavailability. The technology enables the developmentof effective liquid drug products with exceptional cosmetic properties. |  |  | May 28, 2025 |  |
| Nova Anchora | Nova Anchora, a biopharmaceutical startup, is developing a corrected protein therapy for DEB, a severe uncommon skin disease. |  | Venture - Series Unknown | Apr 29, 2025 |  |

4 of 4 investments shown.

## Co-investors
- [Cure EB](https://shizune.co/investors/profile/cure-eb) — VC Fund, 3 deals together
- [EB Medical Research Foundation](https://shizune.co/investors/profile/eb-medical-research-foundation) — VC Fund, 2 deals together
- [EB Research Partnership](https://shizune.co/investors/profile/eb-research-partnership) — VC Fund, 2 deals together
- [ABE](https://shizune.co/investors/profile/abe-2f68) — VC Fund, 1 deal together
- [Empirical Ventures](https://shizune.co/investors/profile/empirical-ventures) — VC Fund, 1 deal together
- [Oshen](https://shizune.co/investors/profile/oshen-61bf) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does DEBRA Research invest in?

DEBRA Research invests primarily in Biotechnology, Fitness and Medical startups, most often at Funding Round and Seed stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did DEBRA Research last invest?

The most recent investment recorded for DEBRA Research closed in Jul 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co